Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Ciba-Geigy describes CGP-59326, a powerful antitumor agent

May 31, 1996

University of Pittsburgh research reveals GGTI-298, a new geranylgeranyltransferase-1 inhibitor

May 31, 1996

Cell signaling inhibitor, CTC-119, antitumor activity reported

May 31, 1996

Merck & Co. reveals protein farnesyltransferase-inhibiting analogues

May 31, 1996

More protein farnesyltransferase inhibitors from Warner-Lambert

May 31, 1996

Research of a recombinant fusion protein in human breast cancer disclosed

May 31, 1996

RPR-112378: A new inhibitor of tubulin polymerization

May 31, 1996

Encouraging results reported in paclitaxel and cisplatin-based therapy combination

May 31, 1996

Topotecan hydrochloride exhibits positive results in recurrent ovarian cancer patients

May 31, 1996

NSC-314622, a new topoisomerase I-targeted antitumor, described by NIH

May 31, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...